The Form 4 filing, a report of an insider's stock trades, was filed on November 13, 2026. The sales by Sean Donovan, chief operating officer of BETA Technologies (BETA), took place on November 10 and 11, 2026.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-11 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 23,167 |
| Price | $28.12 |
| Total Transaction Value | $651,356.38 |
| Insider | |
| Ticker Symbol | BETA |
| Company | BETA Technologies, Inc. |
| Insider Name | Donovan Sean |
| Insider Title | CHIEF OPERATING OFFICER |
| Sector - Industry | Industrials - Aerospace & Defense |
| Holdings | |
| Total Shares Owned After Transaction | 240,972 |
| Position Size Change | 8.77% |
| Filing | |
| Filing Date | 2026-11-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported with transaction code S. The filing information covers two sales by Sean Donovan. It does not specify whether they were open-market or private sales.
What was the average price of the transaction?
The average price was $28.12 per share, rounded to the nearest cent. This average covers both sales. Separate prices for each sale are not available.
How did this transaction affect the insider's holdings?
Sean Donovan sold 23,167 shares and reported owning 240,972 shares afterward. He sold 8.77% of the shares he owned before the sales. The reported balance shows that he still held shares afterward.
What's the total transaction value?
The two sales had a total reported value of $651,356.38, rounded to the nearest cent.
Are there any special circumstances around this transaction?
The filing information identifies a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. The available details do not show whether the reference covers one sale or both. Footnote text is not available to confirm which sales were covered. The plan's start date, schedule, and other terms are unknown.
For research purposes only; not investment advice.